$OCGN + 201% today
$OCGN a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, jump on $23M registered direct offering yesterday night.
This gives to stock a BIG push today after the press release of last week where they announced a deal to co-develop a Covid-10 vaccine.
Here is the graph of the day.
Here is the 30 day overview.